Literature DB >> 34269817

Inhibitory feedback control of NF-κB signalling in health and disease.

Jack A Prescott, Jennifer P Mitchell1, Simon J Cook1.   

Abstract

Cells must adapt to changes in their environment to maintain cell, tissue and organismal integrity in the face of mechanical, chemical or microbiological stress. Nuclear factor-κB (NF-κB) is one of the most important transcription factors that controls inducible gene expression as cells attempt to restore homeostasis. It plays critical roles in the immune system, from acute inflammation to the development of secondary lymphoid organs, and also has roles in cell survival, proliferation and differentiation. Given its role in such critical processes, NF-κB signalling must be subject to strict spatiotemporal control to ensure measured and context-specific cellular responses. Indeed, deregulation of NF-κB signalling can result in debilitating and even lethal inflammation and also underpins some forms of cancer. In this review, we describe the homeostatic feedback mechanisms that limit and 're-set' inducible activation of NF-κB. We first describe the key components of the signalling pathways leading to activation of NF-κB, including the prominent role of protein phosphorylation and protein ubiquitylation, before briefly introducing the key features of feedback control mechanisms. We then describe the array of negative feedback loops targeting different components of the NF-κB signalling cascade including controls at the receptor level, post-receptor signalosome complexes, direct regulation of the critical 'inhibitor of κB kinases' (IKKs) and inhibitory feedforward regulation of NF-κB-dependent transcriptional responses. We also review post-transcriptional feedback controls affecting RNA stability and translation. Finally, we describe the deregulation of these feedback controls in human disease and consider how feedback may be a challenge to the efficacy of inhibitors.
© 2021 The Author(s).

Entities:  

Keywords:  IKKs; IκBs; decoy receptors; deubiquitylases; feedback; nuclear factor κB

Year:  2021        PMID: 34269817      PMCID: PMC8286839          DOI: 10.1042/BCJ20210139

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  368 in total

Review 1.  Molecular mechanisms of long noncoding RNAs.

Authors:  Kevin C Wang; Howard Y Chang
Journal:  Mol Cell       Date:  2011-09-16       Impact factor: 17.970

2.  A20 controls intestinal homeostasis through cell-specific activities.

Authors:  Lars Vereecke; Sara Vieira-Silva; Thomas Billiet; Johan H van Es; Conor Mc Guire; Karolina Slowicka; Mozes Sze; Maaike van den Born; Gert De Hertogh; Hans Clevers; Jeroen Raes; Paul Rutgeerts; Severine Vermeire; Rudi Beyaert; Geert van Loo
Journal:  Nat Commun       Date:  2014-09-30       Impact factor: 14.919

3.  Structures of CYLD USP with Met1- or Lys63-linked diubiquitin reveal mechanisms for dual specificity.

Authors:  Yusuke Sato; Eiji Goto; Yuri Shibata; Yuji Kubota; Atsushi Yamagata; Sakurako Goto-Ito; Keiko Kubota; Jun-ichiro Inoue; Mutsuhiro Takekawa; Fuminori Tokunaga; Shuya Fukai
Journal:  Nat Struct Mol Biol       Date:  2015-02-16       Impact factor: 15.369

Review 4.  Expression, biological activities and mechanisms of action of A20 (TNFAIP3).

Authors:  Lynn Verstrepen; Kelly Verhelst; Geert van Loo; Isabelle Carpentier; Steven C Ley; Rudi Beyaert
Journal:  Biochem Pharmacol       Date:  2010-07-03       Impact factor: 5.858

5.  Cloning and functional characterization of mouse IkappaBepsilon.

Authors:  S Simeonidis; S Liang; G Chen; D Thanos
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

6.  Polymorphism of the pre-miR-146a is associated with risk of cervical cancer in a Chinese population.

Authors:  Cong Yue; Meilin Wang; Bo Ding; Wei Wang; Shilong Fu; Delan Zhou; Zhengdong Zhang; Suping Han
Journal:  Gynecol Oncol       Date:  2011-04-29       Impact factor: 5.482

7.  The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses.

Authors:  David L Boone; Emre E Turer; Eric G Lee; Regina-Celeste Ahmad; Matthew T Wheeler; Colleen Tsui; Paula Hurley; Marcia Chien; Sophia Chai; Osamu Hitotsumatsu; Elizabeth McNally; Cecile Pickart; Averil Ma
Journal:  Nat Immunol       Date:  2004-08-29       Impact factor: 25.606

Review 8.  The role of ubiquitin in NF-kappaB regulatory pathways.

Authors:  Brian Skaug; Xiaomo Jiang; Zhijian J Chen
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

9.  Control of specificity and magnitude of NF-kappa B and STAT1-mediated gene activation through PIASy and PIAS1 cooperation.

Authors:  Samuel Tahk; Bin Liu; Vasili Chernishof; Kelly A Wong; Hong Wu; Ke Shuai
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-02       Impact factor: 11.205

10.  Recruitment of the 4EHP-GYF2 cap-binding complex to tetraproline motifs of tristetraprolin promotes repression and degradation of mRNAs with AU-rich elements.

Authors:  Rui Fu; Myanna T Olsen; Kristofor Webb; Eric J Bennett; Jens Lykke-Andersen
Journal:  RNA       Date:  2016-01-13       Impact factor: 4.942

View more
  16 in total

1.  EPSTI1 promotes monocyte adhesion to endothelial cells in vitro via upregulating VCAM-1 and ICAM-1 expression.

Authors:  Yan-Rou Bei; Shun-Chi Zhang; Yu Song; Mao-Lin Tang; Ke-Lan Zhang; Min Jiang; Run-Chao He; Shao-Guo Wu; Xue-Hui Liu; Li-Mei Wu; Xiao-Yan Dai; Yan-Wei Hu
Journal:  Acta Pharmacol Sin       Date:  2022-07-01       Impact factor: 6.150

2.  Multi-locus SNP analyses of interleukin 1 receptor associated kinases 2 gene polymorphisms with the susceptibility to rheumatoid arthritis.

Authors:  Maham Ghouri; Muhammad Ismail; Syeda Areesha Zaidi; Shafique Rehman; Asadullah Dahani; Saima Saleem; Sitwat Zehra
Journal:  PLoS One       Date:  2022-05-19       Impact factor: 3.752

3.  Concomitant Retinal Alterations in Neuronal Activity and TNFα Pathway Are Detectable during the Pre-Symptomatic Stage in a Mouse Model of Alzheimer's Disease.

Authors:  Virginie Dinet; Louiza Arouche-Delaperche; Julie Dégardin; Marie-Christine Naud; Serge Picaud; Slavica Krantic
Journal:  Cells       Date:  2022-05-16       Impact factor: 7.666

Review 4.  Kirenol: A Potential Natural Lead Molecule for a New Drug Design, Development, and Therapy for Inflammation.

Authors:  Naurah Nabihah Nasir; Mahendran Sekar; Shivkanya Fuloria; Siew Hua Gan; Nur Najihah Izzati Mat Rani; Subban Ravi; M Yasmin Begum; Kumarappan Chidambaram; Kathiresan V Sathasivam; Srikanth Jeyabalan; Arulmozhi Dhiravidamani; Lakshmi Thangavelu; Pei Teng Lum; Vetriselvan Subramaniyan; Yuan Seng Wu; Abul Kalam Azad; Neeraj Kumar Fuloria
Journal:  Molecules       Date:  2022-01-23       Impact factor: 4.411

Review 5.  Understanding Aberrant Signaling to Elude Therapy Escape Mechanisms in Myeloproliferative Neoplasms.

Authors:  Maria Teresa Bochicchio; Valeria Di Battista; Pietro Poggio; Giovanna Carrà; Alessandro Morotti; Mara Brancaccio; Alessandro Lucchesi
Journal:  Cancers (Basel)       Date:  2022-02-15       Impact factor: 6.639

6.  The protective role and mechanism of liriodendrin in rats with myocardial infarction.

Authors:  Bo Li; Bo-Chen Yao; Qing-Liang Chen; Yan-Qiu Song; Nan Jiang; Li-Li Zhao; Zhi-Gang Guo
Journal:  J Thorac Dis       Date:  2022-01       Impact factor: 3.005

7.  IKKα plays a major role in canonical NF-κB signalling in colorectal cells.

Authors:  Jack A Prescott; Kathryn Balmanno; Jennifer P Mitchell; Hanneke Okkenhaug; Simon J Cook
Journal:  Biochem J       Date:  2022-02-11       Impact factor: 3.857

8.  Reciprocal interplay between OTULIN-LUBAC determines genotoxic and inflammatory NF-κB signal responses.

Authors:  Mingqi Li; Ling Li; Sarah Asemota; David Kakhniashvili; Ramesh Narayanan; Xusheng Wang; Francesca-Fang Liao
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-08       Impact factor: 12.779

Review 9.  Punicalagin Regulates Signaling Pathways in Inflammation-Associated Chronic Diseases.

Authors:  Jie Xu; Ke Cao; Xuyun Liu; Lin Zhao; Zhihui Feng; Jiankang Liu
Journal:  Antioxidants (Basel)       Date:  2021-12-24

Review 10.  NF-κB Signaling and Inflammation-Drug Repurposing to Treat Inflammatory Disorders?

Authors:  Annabell Roberti; Laura Elizabeth Chaffey; David R Greaves
Journal:  Biology (Basel)       Date:  2022-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.